$6.050
-1.130 (-18.68%)At close
- High
- 7.445
- Open
- 7.360
- VWAP
- 6.45
- Volume
- 527.23K
- Mkt Cap
- —
- Low
- 5.850
- Amount
- 3.40M
- EV/EBITDA, TTM
- -0.03
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
AI analysis of Axe Compute Inc (AGPU)
HoldAxe Compute Inc is currently not a strong buy due to its low RSI of 31.092 indicating oversold conditions, and a significant recent drop of 41.42% over the last 20 days. While the stock has a potential upside with an analyst price target of $20, the current price of $7.61 suggests that investors should wait for more stability before entering.
Valuation Metrics
Events Timeline
News
2.011-04NewsfilterTech Stocks Surge After Midterm Elections Victory
4.511-04CNBCTech Stocks Surge Following Midterm Election Results
4.510-29NewsfilterAxe Compute Relocates Headquarters to Miami
5.010-21NewsfilterAxe Compute Grants Stock Options to New Employees
7.510-14NewsfilterAxe Compute Partners with Penguin Solutions to Accelerate AI Infrastructure Deployment
AGPU FAQ — answered by Alphio AI
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build. It operates in the Healthcare sector.
Axe Compute Inc is currently not a strong buy due to its low RSI of 31.092 indicating oversold conditions, and a significant recent drop of 41.42% over the last 20 days. While the stock has a potential upside with an analyst price target of $20, the current price of $7.61 suggests that investors should wait for more stability before entering.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.